- Home
- BGLC vs LDWY Comparison
BGLC vs LDWY Comparison
Compare BGLC & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- LDWY
- Stock Information
- Founded
- BGLC 2017
- LDWY 1990
- Country
- BGLC Malaysia
- LDWY United States
- Employees
- BGLC N/A
- LDWY N/A
- Industry
- BGLC Medical Specialities
- LDWY Advertising
- Sector
- BGLC Health Care
- LDWY Consumer Discretionary
- Exchange
- BGLC Nasdaq
- LDWY Nasdaq
- Market Cap
- BGLC 10.7M
- LDWY 9.2M
- IPO Year
- BGLC N/A
- LDWY 1991
- Fundamental
- Price
- BGLC $5.14
- LDWY $4.98
- Analyst Decision
- BGLC
- LDWY
- Analyst Count
- BGLC 0
- LDWY 0
- Target Price
- BGLC N/A
- LDWY N/A
- AVG Volume (30 Days)
- BGLC 3.1M
- LDWY 4.2K
- Earning Date
- BGLC 08-13-2025
- LDWY 08-18-2025
- Dividend Yield
- BGLC N/A
- LDWY N/A
- EPS Growth
- BGLC N/A
- LDWY N/A
- EPS
- BGLC N/A
- LDWY N/A
- Revenue
- BGLC $9,265,870.00
- LDWY $42,183,000.00
- Revenue This Year
- BGLC N/A
- LDWY N/A
- Revenue Next Year
- BGLC N/A
- LDWY N/A
- P/E Ratio
- BGLC N/A
- LDWY N/A
- Revenue Growth
- BGLC N/A
- LDWY 425.12
- 52 Week Low
- BGLC $2.01
- LDWY $3.02
- 52 Week High
- BGLC $15.60
- LDWY $5.53
- Technical
- Relative Strength Index (RSI)
- BGLC 55.54
- LDWY 51.44
- Support Level
- BGLC $3.57
- LDWY $4.50
- Resistance Level
- BGLC $7.05
- LDWY $5.39
- Average True Range (ATR)
- BGLC 1.44
- LDWY 0.36
- MACD
- BGLC -0.04
- LDWY -0.02
- Stochastic Oscillator
- BGLC 25.00
- LDWY 68.22
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.